Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Care Publish Ahead of Print published online ahead of print February 11, 2008
DOI: 10.2337/dc07-2102

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-2102v1
31/5/1026    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metter, E. J.
Right arrow Articles by Ferrucci, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metter, E. J.
Right arrow Articles by Ferrucci, L.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Glucose and Insulin Measurements from the Glucose Tolerance Test and Mortality Prediction

E. Jeffrey Metter, M.D.1, B. Gwen Windham, M.D., M.H.S.1, Marcello Maggio, M.D., Ph.D.2, Eleanor M. Simonsick, Ph.D.1, Shari M. Ling, M.D.1, Josephine M. Egan, M.D.3 and Luigi Ferrucci, M.D., Ph.D.1

1Longitudinal Studies Section, Clinical Research Branch, National Institute on, Aging Intramural Research Program (NIA-IRP), National Institutes of Health (NIH), Baltimore, MD, USA
2Department of Internal Medicine and Biomedical Sciences, Section of Geriatrics, University of Parma, Italy
3Laboratory of Clinical Investigation, National Institute on Aging Intramural Research Program (NIA-IRP), National Institutes of Health (NIH), Baltimore, MD, USA

metterj{at}mail.nih.gov

ABSTRACT

Objective: To verify what information from oral glucose tolerance testing (OGTT) independently predicts mortality.

Research Design and Methods: 1401 initially non-diabetic participants from the Baltimore Longitudinal Study of Aging, aged 17-95 years, with one or more OGTT (median=2, range 1-8) with insulin and glucose measurements measured every 20 minutes over 2 hours. Proportional hazard using the longitudinally collected data and Bayesian model averaging were used to examine the association of OGTT measurements individually and grouped with mortality adjusting for covariates.

Results: Participants were followed for a median 20.3 years (range 0.5 – 40 years). The first hour OGTT glucose and insulin levels increased only modestly with age; whereas levels during the second hour increased more than 4% per decade. Individually, the 100- and 120-minute glucose measures and the fasting and 100-minute insulin levels were all independent predictors of mortality. When all measures were considered together, only higher 120-minute glucose was a significant independent risk factor for mortality.

Conclusion: The steeper rise with age of the OGTT 2-hour glucose values and the prognostic primacy of the 120 minute glucose value for mortality is consistent with previous reports and suggests the value of using the OGTT in clinical practice.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.